Evidence map›Paper›PMID 40092994›Full record

ArticleFrontiers in immunology2025

Berberine hydrochloride enhances innate immunity to protect against pathogen infection via p38 MAPK pathway.

Yi Xiao, Yingwen Cui, Yan Zhang, Wenqiao Fu, Yun Liu, Fang Liu

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Current issues in molecular biology · 2026
    Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Chelerythrine enhances anti-fungi immunity inFrontiers in immunology · 2026
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yi Xiao *Institute of Life Sciences, Zunyi Medical University, Zunyi, Guizhou, China.
Yingwen Cui *Institute of Life Sciences, Zunyi Medical University, Zunyi, Guizhou, China.
Yan Zhang *Institute of Life Sciences, Zunyi Medical University, Zunyi, Guizhou, China.
Wenqiao FuInstitute of Life Sciences, Zunyi Medical University, Zunyi, Guizhou, China.
Yun LiuInstitute of Life Sciences, Zunyi Medical University, Zunyi, Guizhou, China.
Fang LiuInstitute of Life Sciences, Zunyi Medical University, Zunyi, Guizhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The p38 MAPK pathway, an evolutionarily conserved mechanism, plays a crucial role in defending hosts against bacterial infections in both mammals and nematodes. Activating p38 MAPK signaling has been identified as a promising strategy to strengthen innate immunity and enhance resistance to pathogenic infections across various organisms.Berberine hydrochloride (BH), an isoquinoline alkaloid derived from

Indexed as

BerberineImmunity, InnateMAP Kinase Signaling Systemp38 Mitogen-Activated Protein KinasesAnimalsCaenorhabditis elegansCaenorhabditis elegans ProteinsListeria monocytogenesMiceMitogen-Activated Protein KinasesPseudomonas aeruginosaBerberineCaenorhabditis elegans ProteinsMitogen-Activated Protein Kinasesp38 Mitogen-Activated Protein KinasesPmk-1 protein, C elegansBerberine hydrochlorideCaenorhabditis elegansinnate immunitymousep38 MAPK pathway

Identifiers

PMID40092994
PMCPMC11906452

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.